» Articles » PMID: 33598075

Metastasis to the Pancreas: a Rare Site for Secondary Malignancy of Breast Cancer (a Case Report)

Overview
Journal Pan Afr Med J
Date 2021 Feb 18
PMID 33598075
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is the most frequent invasive cancer in women and the second cause of death by cancer in women after lung cancer. It causes metastases especially to bones, liver and lungs. Pancreatic metastases from a primary breast neoplasm are rare and unusual, occurring in less than 3% of the cases. There have been only 28 cases described in the literature. This paper adds one more case to the published literature. We present a case of pancreatic metastasis of the breast in a 64-year-old female and a discussion based on a review of the literature.

Citing Articles

Fine needle aspiration of pancreatic lesions focusing on secondary tumors with emphasis of metastatic breast cancer: A clinicopathological study with follow-up.

Chen M, Zarrin-Khameh N, Xu Y Cancer Med. 2022; 12(5):5485-5493.

PMID: 36281523 PMC: 10028048. DOI: 10.1002/cam4.5374.

References
1.
Tsitouridis I, Diamantopoulou A, Michaelides M, Arvanity M, Papaioannou S . Pancreatic metastases: CT and MRI findings. Diagn Interv Radiol. 2009; 16(1):45-51. DOI: 10.4261/1305-3825.DIR.1996-08.1. View

2.
Apodaca-Rueda M, Chaim F, Garcia M, Saito H, Gestic M, Utrini M . Solitary pancreatic metastasis from breast cancer: case report and review of literature. Sao Paulo Med J. 2017; 137(2):201-205. PMC: 9721236. DOI: 10.1590/1516-3180.2017.0144260617. View

3.
Sperti C, Moletta L, Patane G . Metastatic tumors to the pancreas: The role of surgery. World J Gastrointest Oncol. 2014; 6(10):381-92. PMC: 4197429. DOI: 10.4251/wjgo.v6.i10.381. View

4.
Azzarelli A, Clemente C, Quagliuolo V, Baticci F . A case of pancreatoduodenectomy as resolutive treatment for a solitary metastasis of breast cancer. Tumori. 1982; 68(4):331-5. DOI: 10.1177/030089168206800411. View

5.
Finn R, Crown J, Lang I, Boer K, Bondarenko I, Kulyk S . The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study. Lancet Oncol. 2014; 16(1):25-35. DOI: 10.1016/S1470-2045(14)71159-3. View